Basf Se (OTCMKTS:BASFY – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the nine analysts that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell rating, three have given a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company.
Separately, Citigroup reaffirmed a “buy” rating on shares of Basf in a research report on Thursday, September 3rd.
View Our Latest Research Report on Basf
Basf Stock Performance
Shares of BASFY opened at $14.99 on Friday. The company has a market capitalization of $53.52 billion, a price-to-earnings ratio of 7.73, a price-to-earnings-growth ratio of 1.22 and a beta of 0.76. Basf has a 52-week low of $11.93 and a 52-week high of $16.25. The company has a quick ratio of 1.19, a current ratio of 1.85 and a debt-to-equity ratio of 0.50. The stock has a 50 day moving average price of $14.87 and a 200 day moving average price of $14.74.
Basf (OTCMKTS:BASFY – Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The basic materials company reported $0.37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.24 by $0.13. The company had revenue of $19.99 billion for the quarter, compared to analysts’ expectations of $18.85 billion. Basf had a net margin of 9.40% and a return on equity of 5.66%. Research analysts predict that Basf will post 0.82 EPS for the current fiscal year.
Basf Company Profile
BASF SE is a Germany-based chemical company headquartered in Ludwigshafen, Germany. Founded in 1865, the company develops, manufactures and markets a broad range of chemicals, materials and solutions for industrial, agricultural and consumer applications. Its products are used in areas including transportation, construction, electronics, packaging, food and personal care.
BASF’s business includes chemicals and intermediates, performance materials, coatings, catalysts, battery materials, agricultural products, nutrition and care ingredients, and industrial solutions.
Featured Stories
- Five stocks we like better than Basf
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
Receive News & Ratings for Basf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basf and related companies with MarketBeat.com's FREE daily email newsletter.
